Found 5 matching trials
Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF PHASE3 This study will evaluate the efficacy of switching from emtricitabine/tenof...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC PHASE3 The primary objectives of this study are to evaluate the efficacy, safety, ...
Show More Location
Spectrum Medical Group
Learn More & Join Trial
Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir PHASE3 The purpose of this study is to compare the safety, tolerability and effica...
Show More Location
Southwest Center for HIV/AIDS
Learn More & Join Trial
Radicle Relief RAL™: A Study Assessing the Impact of Health and Wellness Products on Pain Relief and Related Health Outcomes NA Radicle Relief RAL: A randomized, double-blind, placebo-controlled study as...
Show More Location
Radicle Science Inc.
Learn More & Join Trial
A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults PHASE3 ING111762 is a 48 week, randomized, double-blind, active-controlled, multic...
Show More Location
GSK Investigational Site
Learn More & Join Trial